These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [An experimental study of the pharmacological activity of opiate receptor ligands on models of adrenaline-induced arrhythmias]. Lishmanov IuB, Maslov LN, Ugdyzhekova DS. Eksp Klin Farmakol; 1995; 58(4):26-8. PubMed ID: 7580747 [Abstract] [Full Text] [Related]
12. [The use of central administration of the delta1- and delta2-opiate receptor agonists for prevention of the experimental adrenal arrhythmias]. Lishmanov IuB, Ugdyzhekova DS, Maslov LN. Biull Eksp Biol Med; 1997 Sep; 124(9):286-8. PubMed ID: 9445607 [No Abstract] [Full Text] [Related]
16. [The effect of mu-, delta- and kappa-opiate receptor agonists on the bioelectrical activity of the viscerosomatic convergent neurons in the posterior horn of the spinal cord]. Kasparov SA. Eksp Klin Farmakol; 1993 Sep; 56(1):13-6. PubMed ID: 8391888 [Abstract] [Full Text] [Related]
18. [The anti-arrhythmia action of an extract of Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias]. Maĭmeskulova LA, Maslov LN. Eksp Klin Farmakol; 1998 Sep; 61(2):37-40. PubMed ID: 9621172 [Abstract] [Full Text] [Related]
19. Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride. Alexanian AR, Arutyunian NS, Galoyan AA. Arzneimittelforschung; 1996 Dec; 46(12):1110-3. PubMed ID: 9006783 [Abstract] [Full Text] [Related]